Ernexa Therapeutics Inc. (ERNA) Change in Account Payables (2022 - 2026)
Ernexa Therapeutics' (ERNA) quarterly Change in Account Payables came in at -$500000.0 in Q1 2026, up 10.55% on a QoQ basis from -$559000.0 in Q4 2024.
Ernexa Therapeutics Inc. (ERNA) Change in Account Payables (2022 - 2026) Analysis & Trends
Ernexa Therapeutics (ERNA) has 4 years of Change in Account Payables data on file, last reported at -$500000.0 in Q1 2026.
- Quarterly Change in Account Payables changed N/A year-over-year to -$500000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.3 million (changed N/A YoY) and the FY2025 annual result came in at $750000.0, up 162.24% from the prior year.
- Change in Account Payables improved to -$500000.0 in Q1 2026, from -$559000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $3.4 million in Q3 2022 to a low of -$559000.0 in Q4 2024.
- A 4-year average of -$45363.6 and a median of -$437000.0 in 2022 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2023 — Change in Account Payables plunged 112.91% — and 2024, when it surged 152.05%.
- Tracing ERNA's Change in Account Payables over 4 years: stood at -$437000.0 in 2022, then changed by 0.0% to -$437000.0 in 2023, then retreated by 27.92% to -$559000.0 in 2024, then grew by 10.55% to -$500000.0 in 2026.
- The last three Change in Account Payables figures came in at -$500000.0 (Q1 2026), -$559000.0 (Q4 2024), and $228000.0 (Q3 2024), per Business Quant data.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -500,000.00 |
| Mar 31, 2026 | -500,000.00 |
| Dec 31, 2024 | -559,000.00 |
| Dec 31, 2024 | -559,000.00 |
| Sep 30, 2024 | 228,000.00 |
| Sep 30, 2024 | 228,000.00 |
| Jun 30, 2024 | -437,000.00 |
| Jun 30, 2024 | -437,000.00 |
| Mar 31, 2024 | -437,000.00 |
| Mar 31, 2024 | -437,000.00 |
| Dec 31, 2023 | -437,000.00 |
| Dec 31, 2023 | -437,000.00 |
| Sep 30, 2023 | -438,000.00 |
| Sep 30, 2023 | -438,000.00 |
| Jun 30, 2023 | -437,000.00 |
| Jun 30, 2023 | -437,000.00 |
| Mar 31, 2023 | -438,000.00 |
| Mar 31, 2023 | -438,000.00 |
| Dec 31, 2022 | -437,000.00 |
| Dec 31, 2022 | -437,000.00 |